About Neuome
Neuome is a company based in Bengaluru (India) founded in 2020 by Rajani Kanth Vangala. The company has 28 employees as of April 09, 2024. Neuome offers products and services including instaPRESERVE, InstaDetect, and Biobank. Neuome operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bengaluru, India
- Employees 28 as on 09 Apr, 2024
- Founders Rajani Kanth Vangala
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neuome Technologies Private Limited
- Date of Incorporation 16 Apr, 2020
- Jurisdiction Benguluru, Karnataka, India
-
Annual Revenue
$554.15 K (USD)6.74as on Mar 31, 2023
-
Net Profit
$83.79 K (USD)-14.3as on Mar 31, 2023
-
EBITDA
$127.34 K (USD)-10.08as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
28
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuome
Neuome offers a comprehensive portfolio of products and services, including instaPRESERVE, InstaDetect, and Biobank.
Preserves biospecimens without cold-chain for stability.
Provides ultrasensitive point-of-care pathogen testing.
Offers reliable solutions for biosample storage and management.
People of Neuome
Unlock access to complete
Unlock access to complete
Funding Insights of Neuome
Detailed funding history for Neuome
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuome
Investment portfolio details for Neuome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neuome
Detailed financials for Neuome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuome Comparisons
Peer comparison for Neuome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuome
Neuome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Neuome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuome
Complete news archive for Neuome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuome
Neuome was founded in 2020.
Neuome is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rajani Kanth Vangala is the current CEO of Neuome. They have also founded this company.
As of Apr 09, 2024, the latest employee count at Neuome is 28.
Annual revenue of Neuome is $554.15K as on Mar 31, 2023.
Neuome was founded in 2020 and is based in Bengaluru, India. Technologies for therapeutic, prophylactic, and diagnostic applications in the lifesciences sector are developed by the company. Key products include the InstaDetect Pathogen Diagnostic Kit Platform and the InstaPreserve RT system for biospecimen collection, transport, and storage. Research services are provided to tackle challenges in pharmaceutical and biotechnology research and development.
Neuome's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Neuome offers instaPRESERVE, InstaDetect, and Biobank.